arrow
A

Apostolos Bossios

karolinska institutet
H指数:36
被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Adipokines in Obese Asthma: A Complex Relationship Influenced More by Sex, Weight, and Oral Steroid Treatment Than Disease Severity

肥胖性哮喘中的脂肪因子:一种受性别、体重和口服糖皮质激素治疗影响大于疾病严重性的复杂关系

2026-04-030
OAAI
Sensing of metabolic signals via GPR183 promotes occupation of lung macrophage niches by monocytes

通过GPR183感知代谢信号促进单核细胞对肺巨噬细胞生态位的占据

2026-03-032
PRE
Mortality in severe asthma: results from the NORDSTAR cohort

重症哮喘的死亡率——来自NORDSTAR队列的研究结果

2026-03-012
PRE
Multimorbidity phenotypes and associated characteristics in severe asthma: an observational study of European severe asthma registries

重症哮喘的多发病表型和相关特征: 欧洲重症哮喘登记处的一项观察性研究

2026-02-050
OAAI
Accuracy, comprehensiveness and understandability of AI-generated answers to questions from people with COPD: the AIR-COPD Study

AI生成答案的准确性、全面性和易懂性:针对COPD患者问题的AIR-COPD研究

2025-12-160
OAAI
Plasma proteins associated with cardiovascular disease in relation to lung function in SCAPIS

与SCAPIS中肺功能相关的、与心血管疾病相关的血浆蛋白

2025-11-010
OAAI
Predictors of Response to Biologics for Severe Asthma: A Systematic Review and Meta-Analysis

对重症哮喘生物制剂反应的预测因素:一项系统评价和Meta分析

2025-09-160
OAAI
Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational study

症状、未来急性加重的风险以及对长期大环内酯治疗的反应:一项观察性研究

2025-08-270
OAAI
High-Dimensional Analysis of Type 2 Lymphocyte Dynamics During Mepolizumab or Dupilumab Treatment in Severe Asthma

重度哮喘中Mepolizumab或Dupilumab治疗期间淋巴细胞动力学的高维分析

2025-06-260
OAAI
Newly diagnosed eosinophilic granulomatosis with polyangiitis in patients on biologics for severe asthma: A multicenter case series

新诊断的嗜酸性肉芽肿性多血管炎在生物制剂治疗重症哮喘患者中的多中心病例系列

2025-04-150
PRE
Characteristics of severe asthma patients requiring ICU treatment across the SHARP CRC
2024-10-300
PRE